Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of ... ( read original story ...)
BeiGene gets the ball rolling on its 3rd IPO — and this one is expected to fetch $3B
BeiGene was among the first China-based biotech companies to list on Nasdaq and made history by raising $903 million in its secondary listing in Hong Kong. Now, it’s ready to pull a hat trick as it ... ( read original story ...)
STAR Market Daily: STAR 50 falls 0.27%, RMB 59.8 bln traded
Shanghai Stock Exchange STAR 50 closed at 1,472.22 on Wednesday. The STAR Market recorded a total trading volume of 1 bln shares with a turnover value of RMB 59.8 bln, down 4.2% from yesterday. ( read original story ...)
Is the Carbon Market a Financial Market At All?
The United Nations Climate Change Conference (COP 26) is being held in Glasgow, UK. One of the important issues is whether to form a joint carbon Emission Trading Scheme across the world. ( read original story ...)
Jack Ma-Backed Wuxi Diagnostics Considering a Hong Kong IPO
Ltd., a Shanghai-based integrated diagnostics service platform, is weighing an initial public offering in Hong Kong as soon as next year, people with knowledge of the matter said. Most Read from Bloom ... ( read original story ...)
JPMorgan CEO jokes bank will outlast China’s Communist Party
JPMorgan Chase and Co’s Chief Executive Officer Jamie Dimon jokes that his bank will last longer than China’s Communist Party. While reiterating his bank’s commitment to doing business in China, Dimon ... ( read original story ...)
Fitch Rates China Everbright Bank Hong Kong Branch’s Proposed USD Notes ‘BBB(EXP)’
Fitch Ratings has assigned an expected rating of 'BBB(EXP)' to China Everbright Bank Company Limited's (CEB, BBB/Stable/bb-) proposed long-term senior unsecured notes to be issued by (CEB Hong Kong ... ( read original story ...)